4.3 Article

Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales

Journal

INTERNAL MEDICINE JOURNAL
Volume 38, Issue 11, Pages 816-823

Publisher

WILEY
DOI: 10.1111/j.1445-5994.2008.01672.x

Keywords

antineutrophil cytoplasmic antibody; epidemiology; Wegener's granulomatosis; polyarteritis; systemic vasculitis

Ask authors/readers for more resources

Background: The aim of the study was to determine the epidemiology of primary systemic vasculitis in the Australian Capital Territory and the surrounding rural region between 1995 and 2005. Methods: Cases were ascertained by a medical record search according to international consensus classification criteria. For antineutrophil cytoplasmic antibody-associated vasculitides, ascertainment was corroborated by a search of all positive antineutrophil cytoplasmic antibody serology during the study period. Denominators were obtained from region-specific census data collected during the study period. Prevalence, incidence and patient characteristics for primary systemic vasculitides were determined for two 5-year periods, 1995-1999 and 2000-2004. Results: We identified 41 cases of primary systemic vasculitides (Wegener's granulomatosis (WG), microscopic polyangiitis (MPA), Churg-Strauss syndrome or polyarteritis nodosa) between 1995 and 1999 and 67 between 2000 and 2004, giving prevalences of 95/million (95% confidence interval (CI) 76.9-116.1) and 148/million (95% CI 125.1-173.9), respectively. Annual incidence was similar in both periods (approximately 17/year per million adult population). Disease-specific incidences (per million per year) for each of the two periods were 8.8 and 8.4 for WG, 2.3 and 5.0 for MPA, 2.3 and 2.2 for Churg-Strauss syndrome and 2.3 and 1.1 for polyarteritis nodosa. The rural incidence of MPA was 13.9 (95% CI 7.7-23.5) compared with 1.6 (95% CI 0.2-7.2) in the city and there was a trend towards a higher incidence of WG in rural than urban areas. Conclusion: The overall incidence of primary systemic vasculitides is similar to that reported from other developed countries. WG is more common in southeastern Australia than in southern Europe, whereas MPA is less common. There was a trend towards higher incidence of antineutrophil cytoplasmic antibody-associated vasculitides in rural than urban areas.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Editorial Material Health Care Sciences & Services

Personalizing Medicine and Technologies to Address the Experiences and Needs of People with Multiple Sclerosis

Adam Henschke, Jane Desborough, Anne Parkinson, Crystal Brunoro, Vanessa Fanning, Christian Lueck, Nicola Brew-Sam, Anne Brustle, Janet Drew, Katrina Chisholm, Mark Elisha, Hanna Suominen, Antonio Tricoli, Christine Phillips, Matthew Cook

Summary: The research identifies five experiential themes of PwMS and interprets these themes based on the foundations of personalized medicine, providing a roadmap for implementing personalized medicine solutions for PwMS.

JOURNAL OF PERSONALIZED MEDICINE (2021)

Article Genetics & Heredity

Expanding the clinical spectrum of pathogenic variation in NR2F2: Asplenia

Todor Arsov, Jadranka Kelecic, Sanda Huljev Frkovic, Mario Sestan, Nastasia Kifer, Dan Andrews, Marcin Adamski, Marija Jelusic, Matthew C. Cook

Summary: This case report presents a rare syndrome of congenital syndromic asplenia associated with immune deficiency, glandular hypospadias, and cryptorchidism, with a likely pathogenic de novo variant in the NR2F2 gene identified through genetic analysis. The study expands the clinical spectrum of NR2F2 in humans to include asplenia, with previous associations in animal models.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2021)

Article Pathology

Correlation of haemophagocytosis with clinical criteria of haemophagocytic lymphohistiocytosis and recommendations for bone marrow reporting

C. Wilson, W. Lee, M. C. Cook, L. Smyth, D. Talaulikar

Summary: This study aimed to assess the correlation between the amount of haemophagocytosis identified in bone marrow and the HLH-2004 criteria. The findings indicate that the amount of haemophagocytosis present on bone marrow samples correlates with the number of HLH-2004 criteria. The study also highlights the need for recommendations to improve the consistency in reporting haemophagocytosis.

PATHOLOGY (2022)

Review Immunology

Inborn Errors of Immunity and Their Phenocopies: CTLA4 and PD-1

Yuwei Hao, Matthew C. Cook

Summary: Understanding the relationship between genotype and phenotype in patients with rare immune disorders is crucial for unraveling mechanisms of immune regulation. This study focuses on autosomal dominant and recessive IEIs, investigating the complex genotype-phenotype relationships and the occurrence of phenocopies. The research highlights the importance of studying drug-induced phenocopies in cancer patients treated with immune checkpoint inhibitors to gain further insights into disease mechanisms.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Subcutaneous Gammanorm® by pump or rapid push infusion: Impact of the device on quality of life in adult patients with primary immunodeficiencies

Klaus Warnatz, Stephen Jolles, Carlo Agostini, Fabrizio Vianello, Michael Borte, Claire Bethune, Sofia Grigoriadou, Alex Richter, Rashmi Jain, David M. Lowe, Constance Katelaris, Cinzia Milito, Matthew C. Cook

Summary: The study compared the impact of immunoglobulin treatment administered via pump or rapid push injection, with findings showing that rapid push had more frequent administrations but lower total time expenditure and some costs, and performed better in some aspects of quality of life and treatment interference.

CLINICAL IMMUNOLOGY (2022)

Editorial Material Medicine, General & Internal

Dynamic consent and personalised medicine

Liza Goncharov, Hanna Suominen, Matthew Cook

Summary: Dynamic consent has the potential to facilitate the achievement of personalized medicine goals.

MEDICAL JOURNAL OF AUSTRALIA (2022)

Article Multidisciplinary Sciences

TLR7 gain-of-function genetic variation causes human lupus

Grant J. Brown, Pablo F. Canete, Hao Wang, Arti Medhavy, Josiah Bones, Jonathan A. Roco, Yuke He, Yuting Qin, Jean Cappello, Julia I. Ellyard, Katharine Bassett, Qian Shen, Gaetan Burgio, Yaoyuan Zhang, Cynthia Turnbull, Xiangpeng Meng, Phil Wu, Eun Cho, Lisa A. Miosge, T. Daniel Andrews, Matt A. Field, Denis Tvorogov, Angel F. Lopez, Jeffrey J. Babon, Cristina Aparicio Lopez, Africa Gonzalez-Murillo, Daniel Clemente Garulo, Virginia Pascual, Tess Levy, Eric J. Mallack, Daniel G. Calame, Timothy Lotze, James R. Lupski, Huihua Ding, Tomalika R. Ullah, Giles D. Walters, Mark E. Koina, Matthew C. Cook, Nan Shen, Carmen de Lucas Collantes, Ben Corry, Michael P. Gantier, Vicki Athanasopoulos, Carola G. Vinuesa

Summary: Enhanced Toll-like receptor 7 (TLR7) signaling has been associated with human systemic autoimmune disease, but evidence of TLR7 gene variants causing lupus is lacking. In this study, researchers identified a newly described TLR7(Y264H) variant that increased sensing of guanosine and 2',3'-cGMP and was sufficient to cause lupus in mice. Enhanced TLR7 signaling was shown to drive aberrant B cell survival and the accumulation of specific B cell subsets, while deficiency of the downstream adapter protein MyD88 rescued autoimmunity and all phenotypes. The study highlights the importance of TLR7 and guanosine-containing self-ligands in the pathogenesis of lupus and suggests potential therapeutic targets.

NATURE (2022)

Article Immunology

Immune Dysregulation in Monogenic Inborn Errors of Immunity in Oman: Over A Decade of Experience From a Single Tertiary Center

Tariq Al Farsi, Khwater Ahmed, Jalila Alshekaili, Mahmood Al Kindi, Matthew Cook, Aliya Al-Hosni, Zainab Ansari, Iman Nasr, Nashat Al Sukaiti

Summary: This study retrospectively reports the clinical features and outcomes of 239 Omani patients with IEI. The incidence and epidemiological characteristics of IEI in Oman are associated with consanguinity. Immune dysregulation is a common manifestation in these patients and early detection and intervention can improve patient outcomes.

FRONTIERS IN IMMUNOLOGY (2022)

Review Medicine, General & Internal

Diagnostic delay of myositis: protocol for an integrated systematic review

Tergel Namsrai, Jane Desborough, Anita Chalmers, Christine Lowe, Matthew Cook, Christine Phillips, Anne Parkinson

Summary: This study aims to review the diagnostic delay in idiopathic inflammatory myopathies (IIM) and provide an overview of patients' experiences, causes, and consequences of diagnostic delay in myositis. The lack of accurate diagnostic tests and unified diagnostic criteria for IIM may lead to delays in diagnosis.

BMJ OPEN (2022)

Article Medicine, General & Internal

The current understanding of precision medicine and personalised medicine in selected research disciplines: study protocol of a systematic concept analysis

Nicola Brew-Sam, Anne Parkinson, Christian Lueck, Ellen Brown, Karen Brown, Anne Bruestle, Katrina Chisholm, Simone Collins, Matthew Cook, Eleni Daskalaki, Janet Drew, Harry Ebbeck, Mark Elisha, Vanessa Fanning, Adam Henschke, Jessica Herron, Emma Matthews, Krishnan Murugappan, Dragomir Neshev, Christopher J. Nolan, Lachlan Pedley, Christine Phillips, Hanna Suominen, Antonio Tricoli, Kristine Wright, Jane Desborough

Summary: Precision medicine and personalized medicine are key concepts in health-related research, but their application and interpretation vary across disciplines, leading to confusion regarding their use and distinction.

BMJ OPEN (2022)

Review Pediatrics

Skin manifestations of inborn errors of NF-κB

Yitong Shen, Anne P. R. Boulton, Robert L. L. Yellon, Matthew C. C. Cook

Summary: This article summarizes over 400 single gene defects that are inborn errors of immunity, including those affecting NF-kappa B activity. The authors provide an overview of the skin phenotypes in these disorders and discuss the underlying mechanisms.

FRONTIERS IN PEDIATRICS (2023)

Review Multidisciplinary Sciences

Diagnostic delay of sarcoidosis: Protocol for an integrated systematic review

Tergel Namsrai, Christine Phillips, Jane Desborough, Dianne M. Gregory, Elaine Kelly, Matthew Cook, Anne Parkinson

Summary: This study aims to systematically review the evidence on diagnostic delay in sarcoidosis to elucidate the factors associated with diagnostic delay and the consequences for people with sarcoidosis in different contexts and settings.

PLOS ONE (2023)

Article Immunology

CTLA4 protects against maladaptive cytotoxicity during the differentiation of effector and follicular CD4+ T cells

Yuwei Hao, Bahar Miraghazadeh, Rochna Chand, Ainsley R. Davies, Chelisa Cardinez, Kristy Kwong, Morgan B. Downes, Rebecca A. Sweet, Pablo F. Canete, Lloyd J. D'Orsogna, David A. Fulcher, Sharon Choo, Desmond Yip, Geoffrey Peters, Sonia Yip, Matthew J. Witney, Maxim Nekrasov, Zhi-Ping Feng, David C. Tscharke, Carola G. Vinuesa, Matthew C. Cook

Summary: Chronic antigenic stimulation in primary antibody deficiency (PAD) patients provides insights into T-cell differentiation and how environmental exposures modify clinical phenotypes caused by single-gene defects. CD57 marks dysfunctional T cells that have differentiated after antigenic stimulation. CD57(+) CD4(+) T cells are increased in PAD patients and significantly increased with CTLA4 haploinsufficiency or blockade, exhibiting a cytotoxic transcriptome similar to CD8(+) effector cells, killing B cells, and inhibiting B-cell responses. CTLA4 restrains the formation of cytotoxic CD4(+) T cells.

CELLULAR & MOLECULAR IMMUNOLOGY (2023)

Article Immunology

Immunophenotyping identifies distinct cellular signatures for systemic lupus erythematosus and lupus nephritis

Yi Tong V. Aw, Phillip J. Whiley, Ayla May Lorenzo, Tom Lea-Henry, Somasundhari Shanmuganandam, Maurice Stanley, Sonia N. Babu, Vicki Athanasopoulos, Jean Cappello, Julia I. Ellyard, Matthew Cook, Carola Vinuesa, Giles Walters, David A. Fulcher, Simon H. Jiang

Summary: SLE patients with and without lupus nephritis exhibit distinct immunologic differences, which may reflect the unique pathophysiological processes contributing to disease manifestations.

RHEUMATOLOGY & AUTOIMMUNITY (2023)

Article Immunology

Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility

Rushika C. Wirasinha, Ainsley R. Davies, Monika Srivastava, Julie M. Sheridan, Xavier Y. X. Sng, Ottavia M. Delmonte, Kerry Dobbs, Khai L. Loh, Lisa A. Miosge, Cindy Eunhee Lee, Rochna Chand, Anna Chan, Jin Yan Yap, Michael D. Keller, Karin Chen, Jamie Rossjohn, Nicole L. La Gruta, Carola G. Vinuesa, Hugh H. Reid, Michail S. Lionakis, Luigi D. Notarangelo, Daniel H. D. Gray, Christopher C. Goodnow, Matthew C. Cook, Stephen R. Daley

Summary: Mutations in the p100 degron domain increase degradation resistance and lead to autoimmune diseases in mice. Both affected humans and mice show a hydrophobic signature of increased self-reactivity in their T cell receptor repertoires.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

No Data Available